Abstract: Biodegradable polymers have gained enormous attentions in the pharmaceutical and biomedical applications, especially in drug delivery. In this work, we report the synthesis and characteristics of high molecular weight polyoxalate with ∼75000 Da. Hydrolytic degradation kinetics and degradation products were characterized by nuclear magnetic resonance and gel permeation chromatography. Polyoxalate is a semicrystalline and thermally stable polymer with a glass transition temperature of ∼35 ℃, which is suitable for drug delivery applications. The hydrophobic nature of polyoxalate allows it to be formulated into nanoparticles and encapsulate drugs using a conventional oil-in-water emulsion/solvent displacement method. Polyoxalate nanoparticles also exhibited excellent cytotoxicity profiles. It can be suggested that polyoxalate has great potential for numerous biomedical and pharmaceutical applications.
Introduction
There has been considerable interest in the development of biodegradable polymers for the achievement of clinical applications over the past two decades. 1 Degradation of polymer means that physical properties change from chemical reactions including the polymer backbone and side chains.
Heat, photoelectron, microbial metabolism are well known as causes of physical property changes or chemical reactions.
The polymer which has biodegradable properties has been utilized to deliver drugs effectively to a target site and improve the pharmacological and therapeutic activity of drugs while minimizing adverse side effects and reducing the dose. 2 Biodegradable polymers have been widely used for controlled drug delivery vehicles and devices owing to these advantages. 3 The polymers used in drug delivery vehicles can be divided into two categories. One is a synthetic polymer group such as poly(lactide-co-glycolide) (PLGA), polycaprolactone (PCL) and polyanhydride. 4, 5 The other is a natural polymer group such as keratin, chitosan, fibrin, silk, collagen and so on. Among them, PLGA is approved by the United StateFood and Drug Administration and has been most commonly used in pharmaceutical applications. 6, 7 PLGA is also capable 폴리머, 제34권 제6호, 2010년 of controlling degradation kinetics by varying the ratios of lactide and glycolide component. 8 For these reasons, PLGA has been widely applied for drug delivery vehicles and porous scaffolds in tissue engineering. 4 However, its clinical applications are sometimes impeded by its acidic products, which can lead to an inflammation response. Additionally, the use of PLGA has a limitation for the fast drug delivery because of slow hydrolysis kinetics. 3, 9 Polyoxalate has been previously developed for biomedical applications such as drug delivery devices and sutures. 10, 11 It was synthesized from a complicate two-step reaction of ester interchange reaction of diols with ester of oxalic acid, preferably diethyl oxalate in the presence of catalyst such as stannous octoate. Polyoxalate was known to degrade by water hydrolysis into small compounds that can be easily removed from a body. There have been, however, no implications on the nanoparticles formulation based on polyoxalate.
In our laboratory, we developed polyoxalate (POX) from a simple reaction of oxalyl chloride and 1,4-cyclohexanemethanol in the presence of triethylamine. The polyoxalate showed a molecular weight of ∼15000 Da and favorable physicochemical properties for the formulation of nanoparticles with a mean diameter of ∼500 nm. 10 They also exhibited excellent biocompatibility and biodegradation profiles.
In order to broaden the pharmaceutical and biomedical applications of polyoxalate and overcome the limitations of PLGA, we have developed a high molecular weight polyoxalate. In this study, we synthesized polyoxalate using oxalyl chloride and cyclohexanedimethanol in the presence of pyridine. We could obtain biodegradable polyoxalate with a molecular weight, ∼75000 Da using a weaker base pyridine.
Herein, we report the physicochemical, thermal and biological properties of biodegradable high molecular weight polyoxalate.
Experimental
Materials. Oxalyl chloride, 1,4-cyclohexanedimethanol, dichloromethane (DCM), and poly(vinyl alcohol) (PVA) were purchased from Sigma-Aldrich (St. Louis, MO. USA). Pyridine was obtained from Junsei Chemical (Japan). The reagents were used without further purification. 
Results and Discussion
Synthesis and Characterization of Polyoxalate. Polyoxalate was synthesized from a one-step reaction of oxalyl chloride The NMR spectra clearly support the successful synthesis of polyoxalate.
Polyoxalate obtained from this reaction was determined to have a molecular weight of ∼75000 Da, corresponding to a degree of polymerization of ∼350 repeating units (Figure 3) , with a polydispersity index of ∼1.8 and therefore has potential for formulation into nanoparticles. Previously, we synthesized polyoxalate using triethylamine as a base, which had a molecular weight ∼15000 Da. The significant increase in the molecular weight of polyoxalate synthesized using pyridine may be due to less degradation during the polymerization reaction. Peroxalate ester groups are known to undergo degradation which is accelerated under a basic condition. 13, 14 We speculate that the use of pyridine, a weak base resulted in the less degradation and therefore significant increase in the molecular weight.
Polyoxalate is known to degrade via hydrolysis under physiological conditions. 10, 15 The degradation kinetics of polyoxalate was investigated by measuring its molecular weight using GPC. Figure 4 shows that polyoxalate degrades hydrolytically, having a half-life of ∼5 days. Peroxalate ester linkages in the backbone readily become cleaved although polyoxalate has a hydrophobic cycloalphatic chain in its backbone. PLGA is known to have a half-life of several weeks, depending on the molecular weight and ratios of lactide and glycolide and therefore polyoxalate seems to degrade faster than PLGA. 16, 17 It can be expected that polyoxalate nanoparticles will have fast drug release kinetics, suitable for the treatment of acute inflammatory diseases such as acute liver failure and acute lung injury.
Thermal and Physical Properties of Polyoxalate. The thermal stability of polyoxalate was studied using TGA. The thermogram is illustrated in Figure 5(a) . A slight weight loss was observed at ∼120 ℃. The onset of major weight loss took place at polymer decompose at ∼300 ℃. The DSC thermogram of quenched polyoxalate is represented in Figure   5 (b). The glass transition temperature (T g ) is well defined at ∼35 ℃. The low T g may be attributed to the linear and flexible aliphatic chain of the backbone. It was also found that polyoxalate is semicrystalline, with crystallization temperature and melting temperature at 90 and 160 ℃, respectively. Low molecular weight polyoxalate was also subjected to DSC study. However, no difference was observed in thermal behaviors between high molecular and low molecular polyoxalate (data not shown). It can be anticipated that polyoxalate is useful for drug delivery applications because T g is close to a body temperature. Hydrophobic and semicrystalline polymers have been widely used for drug delivery applications in the formation of nano/microparticles and 3-dimensional tissue engineering scaffolds. Semicrystalline polymers with T g around 37 ℃ are soft and flexible in a body.
In addition, their hydrolysis is accelerated in a body because water easily diffuses into the amorphous regions of polymers.
X-ray diffraction of polyoxalate films is shown in Figure 6 .
As evidenced in DSC showing a crystallization of polyoxalate, a large distinct diffraction peak is observed at ∼20°, indicating a spacing of 4.5 Å, which is characteristic of and average distance between two neighboring chain molecules. It seems that polyoxalate has less crystallinity than PLGA because bulky aliphatic cyclic rings in its backbone reduce the molecular mobility and packing capability.
Properties of Polyoxalate Nanoparticles. Polyoxalate is hydrophobic and semicrystalline polymer and suitable for the nanoparticle formulation. The polyoxalate nanoparticles were prepared using a single emulsion/solvent displacement method and observed using SEM. They were round spheres with smooth surface and had a mean diameter of ∼550 nm 
Conclusions
A polymerization reaction of oxalyl chloride and 1,4-cyclohexanedimethanol was conducted in the presence of pyridine to generate a high molecular weight biodegradable polymer.
The obtained polymer had a molecular weight of 75000 Da, which might be due to the less degradation during the polymerization under weak basic conditions. Thermal analysis revealed that polyoxalate was thermally stable and semicrystalline with T g of 35 ℃. The polyoxalate hydrolytically degraded into two small compounds with a half-life of 5 days.
Polyoxalate was hydrophobic and could be formulated into nanoparticles with smooth surface and ∼500 nm diameter.
MTT assay showed that polyoxalate nanoparticles exhibited excellent cytotoxicity. Given their appealing features such as the ease of synthesis and excellent biocompatibility, polyoxalate nanoparticles may have great potential for pharmaceutical and biomedical applications. 
